Chemical Compound
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
CAS Registry Number
108736-35-2
Primary record
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- 库存
- 1,403 克
- 纯度
- 99.7 %
- CAS
- 108736-35-2
化合物标识与属性
- CAS
- 108736-35-2
- PubChem CID
- 6918011
- SMILES
- C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)N)O
- Canonical SMILES
- CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccc3ccccc3c2)CSSC[C@@H](C(=O)N[C@H](C(N)=O)[C@@H](C)O)NC1=O
名称与同义词
- Lanreotide
- Angiopeptin
- Ipstyl
- Lanreotida
- Lanreotide acetate
- Lanreotidum
- Somatulin
- Autogel
- Lanreotide Autogel
- Dermopeptin
- Somatulina
- Somatulin-Autogel
- Somatuline Depot
- Somatuline LA
- 188Re-lanreotide
- 108736-35-2
- Lanreotide [INN:BAN]
- AC1OCEWT
- Lanreotidum [INN-Latin]
- Lanreotida [INN-Spanish]
- RefChem:56442
- Bim-23014
- UNII-0G3DE8943Y
- BIM 23014
- Lanreotide,Lanreotide Acetate
- C54H69N11O10S2
- DTXSID60897514
- 0G3DE8943Y
- orb1705579
- 108736-35-2free base
- CHEMBL1201185
- SCHEMBL29356077
- SCHEMBL29402091
- SCHEMBL29450601
- BDBM82470
- 108736-35-2 (free base)
- H01CB03
- BIM 23014C
- DTXCID601326869
- BIM-23014 C
- HY-P1959
- DC 13-116
- MFCD00873576
- MFCD03424071
- Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2
- AKOS030573447
- ACN-049495
- BAT-010202
- CID6918011
- D-Nal-cys-tyr-trp-lys-val-cys-thr-NH2
- AC-38405
- BP-43730
- BP-43731
- DC 13116
- DC13-116
- FL110376
- C54-H69-N11-O10-S2
- 118992-92-0
- DC-13-116
- CS-0103335
- Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2
- NS00005999
- C71317
- (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-->7)-disulfide
- naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2
- A857302
- B-naphthyl-D-ala-cys-tyr-D-trp*lys-val-cys-thr am
- Q1707877
- (4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- 3-(2-Naphthyl)-D-ala-cys-tyr-D-trp-lys-val-cys-thr-NH2
- BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE
- L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
- 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide
- 3-(2-Naphthyl)alanyl-cystinyl-tyrosyl-tryptophyl-lysyl-valyl-cystinyl-threonine amide
- 3-(2-Naphtyl)-D-Ala-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys(1)-L-Thr-NH2
- naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide
- (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-(2-naphthyl)propanoyl]amino]-N-[(1S,2R)-1-carbamoyl-2-hydroxy-propyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-19-{[3-(naphthalen-2-yl)-D-alanyl]amino}-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-((2-amino-3-naphthalen-2-ylpropanoyl)amino)-16-((4-hydroxyphenyl)methyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
- 127984-74-1
- 2-({19-2-amino-3-(naphthalen-2-yl)propanamido-10-(4-aminobutyl)-16-(4-hydroxyphenyl)methyl-13-(1H-indol-3-yl)methyl-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}formamido)-3-hydroxybutanamide
- 2378114-72-6
- 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-7)-disulfide
- L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide
- L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2 inverted exclamation marku7)-disulfide